| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Rapid Communications |
Institute for Hormone and Fertility Research (AM.B., I.T., I.E., C.M.B., H.M.S.); University of Hamburg, Hamburg, Germany; Department of Pathology (S.L.A.), Mount Sinai Hospital, Samuel Lunenfeld Research Institute, University of Toronto, Toronto, Ontario, Canada
Address correspondence to: Ana-Maria Bamberger, IHF Institute for Hormone and Fertility Research, University of Hamburg, Grandweg 64, 22529 Hamburg, Germany.
Abstract
The Fas (Apo-1/CD95) ligand (FasL) belongs to the tumor necrosis factor family and acts through its receptor (FasR/Apo-1/CD95) to induce apoptosis in target cells. FasL is expressed in several immunologically privileged sites. Induction of apoptosis by FasL in invading lymphocytes acts as a mechanism of immune privilege and is important in preventing graft rejection. Furthermore, FasL is expresssed in certain malignancies and it has been implicated as a possible key mechanism in immune privilege of these tumors. Since the invading placental trophoblast is another very important site with a privileged immune status, we investigated whether FasL is expressed in the normal and tumoral human placenta. For this purpose, mRNA was extracted from first and third trimester human placental samples as well as from JEG3 choriocarcinoma cells and reverse transcribed to obtain cDNAs. These were used as templates for PCR analysis of FasL expression, in which specific primers were employed to amplify an 853 bp fragment spanning the whole FasL coding region. A product of the appropriate length was amplified from normal placenta as well as from the choriocarcinoma cells. Expression of FasL protein was confirmed by Western Blot and was localized to trophoblast by immunohistochemistry using a FasL-specific antibody. Expression of FasL in the human placenta indicates that induction of apoptosis in lymphocytes by the invading trophoblast could be an important mechanism implicated in the immune tolerance of the fetal semi-allograft.
Received June 26, 1997.
Revised July 22, 1997.
Accepted July 22, 1997.
This article has been cited by other articles:
 |
|
 |
|
  I. Sziller, P. Hupuczi, N. Normand, A. Halmos, Z. Papp, and S. S. Witkin Fas (TNFRSF6) Gene Polymorphism in Pregnant Women With Hemolysis, Elevated Liver Enzymes, and Low Platelets and in Their Neonates. Obstet. Gynecol., March 1, 2006; 107(3): 582 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Straszewski-Chavez, V. M. Abrahams, and G. Mor The Role of Apoptosis in the Regulation of Trophoblast Survival and Differentiation during Pregnancy Endocr. Rev., December 1, 2005; 26(7): 877 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Sziller, D. Nguyen, A. Halmos, P. Hupuczi, Z. Papp, and S. S. Witkin An A>G polymorphism at position -670 in the Fas (TNFRSF6) gene in pregnant women with pre-eclampsia and intrauterine growth restriction Mol. Hum. Reprod., March 1, 2005; 11(3): 207 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Poulaki, C. S. Mitsiades, C. McMullan, G. Fanourakis, J. Negri, A. Goudopoulou, I. X. Halikias, G. Voutsinas, S. Tseleni-Balafouta, J. W. Miller, et al. Human Retinoblastoma Cells Are Resistant to Apoptosis Induced by Death Receptors: Role of Caspase-8 Gene Silencing Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 358 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Frangsmyr, V. Baranov, O. Nagaeva, U. Stendahl, L. Kjellberg, and L. Mincheva-Nilsson Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level Mol. Hum. Reprod., January 1, 2005; 11(1): 35 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Riley, J. M. Heeley, A. H. Wyman, E. L. Schlichting, and K. H. Moley TRAIL and KILLER Are Expressed and Induce Apoptosis in the Murine Preimplantation Embryo Biol Reprod, September 1, 2004; 71(3): 871 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Abrahams, S. L. Straszewski-Chavez, S. Guller, and G. Mor First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis Mol. Hum. Reprod., January 1, 2004; 10(1): 55 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ka and J. S. Hunt Temporal and Spatial Patterns of Expression of Inhibitors of Apoptosis in Human Placentas Am. J. Pathol., August 1, 2003; 163(2): 413 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sapi, W. D. Brown, S. Aschkenazi, C. Lim, A. Munoz, B. M. Kacinski, T. Rutherford, and G. Mor Regulation of Fas Ligand Expression By Estrogen in Normal Ovary Reproductive Sciences, July 1, 2002; 9(4): 243 - 250. [Abstract] [PDF]
|
|
|
|
|
|
S. Aschkenazi, S. Straszewski, K. M.A. Verwer, H. Foellmer, T. Rutherford, and G. Mor Differential Regulation and Function of the Fas/Fas Ligand System in Human Trophoblast Cells Biol Reprod, June 1, 2002; 66(6): 1853 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Miyaura and M. Iwata Direct and Indirect Inhibition of Th1 Development by Progesterone and Glucocorticoids J. Immunol., February 1, 2002; 168(3): 1087 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Harirah, S. E. Donia, and C.-D. Hsu Serum Soluble Fas in the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelets Obstet. Gynecol., August 1, 2001; 98(2): 295 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gruslin, Q. Qiu, and B. K. Tsang X-Linked Inhibitor of Apoptosis Protein Expression and the Regulation of Apoptosis During Human Placental Development Biol Reprod, April 1, 2001; 64(4): 1264 - 1272. [Abstract] [Full Text]
|
|
|
|
|
|
S. Wongweragiat, R. F. Searle, and J. N. Bulmer Expression of Fas/Fas Ligand by Decidual Leukocytes in Hydatidiform Mole Biol Reprod, March 1, 2001; 64(3): 784 - 789. [Abstract] [Full Text]
|
|
|
|
|
|
A. D. ALLAIRE, K. A. BALLENGER, S. R. WELLS, M. J. MCMAHON, and B. A. LESSEY Placental Apoptosis in Preeclampsia Obstet. Gynecol., August 1, 2000; 96(2): 271 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shimizu, A. Fontana, Y. Takeda, H. Yagita, T. Yoshimoto, and A. Matsuzawa Induction of Antitumor Immunity with Fas/APO-1 Ligand (CD95L)-Transfected Neuroblastoma Neuro-2a Cells J. Immunol., June 15, 1999; 162(12): 7350 - 7357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Kauma, T. F. Huff, N. Hayes, and A. Nilkaeo Placental Fas Ligand Expression Is a Mechanism for Maternal Immune Tolerance to the Fetus J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2188 - 2194. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. G. Sinkovics, J. C. Horvath, S. Savitz, and S. W. Hetts Role of Apoptosis in Health and Disease JAMA, June 3, 1998; 279(21): 1699 - 1700. [Full Text] [PDF]
|
|
|
|
|
|
N. Mitsiades, V. Poulaki, V. Kotoula, G. Mastorakos, S. Tseleni-Balafouta, D. A. Koutras, and M. Tsokos Fas/Fas Ligand Up-Regulation and BCL-2 Down-Regulation May Be Significant in the Pathogenesis of Hashimoto's Thyroiditis J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2199 - 2203. [Abstract] [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
